Study: Epstein Barr Virus Can Cause Depression in Pregnant Women; polyDNA Recommends Gene-Eden-VIR against the Latent EBV

A study published on June 3, 2013 in the journal Scientific Reports found that “maternal depressive symptoms in late pregnancy are associated with Epstein-Barr virus reactivation (1).” polyDNA reviews the study and recommends Gene-Eden-VIR to those planning a pregnancy, and to those who have given birth.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Herpes treatment
EBV infected women should take Gene-Eden-VIR to help their immune systems target the latent virus before conception, and after giving birth. – Mike Evans, polyDNA

Rochester, NY (PRWEB) November 24, 2013

Reactivation of the latent Epstein Barr Virus (EBV) can cause depression in women, both during, and after pregnancy. Many pregnant women are infected with EBV. In fact, “about 90% of women have serologic evidence of previous infection (1).” In addition to depression in the mother, a reactivation of EBV during pregnancy can cause dangerous conditions in babies. For them, EBV can cause “severe symmetrical fetal growth restriction (growth problems), lower birth weight, and leukemia (1).”

Maternal depression is a mood disorder that begins before or immediately after childbirth. Between 12.7% and 23% of pregnant women will experience a depressive disorder. Researchers found that “women with depression had higher prevalence of EBV reactivation (1).”

The bottom line is that EBV can cause depression in women during pregnancy, and afterwards. “In this study, we found women with depressive symptoms during 32 gestational weeks had significant higher prevalence of EBV reactivation before delivery than nondepressed healthy women… maternal depression was significantly associated with EBV reactivation (1).”

polyDNA therefore recommends Gene-Eden-VIR to women as a preparation for pregnancy. “EBV infected women should take Gene-Eden-VIR to help their immune systems target the latent virus before conception, and after giving birth.” – Mike Evans, polyDNA

A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced herpes symptoms. Study authors wrote that, “Individuals infected with the herpes virus…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (2).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (2).”

To learn more about Gene-Eden-VIR, and EBV, visit http://gene-eden-kill-virus.com/EBV.php. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy.
     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813936/
(2) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study
     http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.